Posted in | News | Medical Optics

AUA 2015: Lumenis and Distinguished Urologists to Host Educational Symposium and Instructive Workshop Series

Lumenis Ltd., the world's largest energy-based medical device company for surgical, ophthalmology, and aesthetic applications announced today that the company will host an educational symposium, in collaboration with nationally distinguished urologists, and an instructive workshop series at the American Urological Association's (AUA) 2015 Annual Meeting, being held in New Orleans, La., from May 15 – 19, 2015.

The educational symposium will feature speaker Marc Beaghler, MD, MPH, Urological Surgery & Pediatric Urology Specialist of San Buenaventura Urology Center, who will talk about Vaporization of the prostate with the Lumenis Pulse 120H and Xpeeda™ fiber, and speaker Khurshid Ghani, MBChB, Assistant Professor, Urology of the University of Michigan, who will talk about the Stone-Dusting™ technique for renal and ureteral stones.

The Lumenis Pulse 120H boasts 120 watts of optical power, and is accompanied by a range of fibers and accessories that are designed to offer optimal energy utilization, accelerated procedure time, along with a pulse reshaping technology resulting in improved hemostasis.

"I have been using the Lumenis Pulse™ 120H laser with the Xpeeda™ fiber for the treatment of BPH performing the Holmium Vaporization technique and have experienced a dramatic improvement in operative workflow," said Stephen L. Brewer, MD, FACS, Urology Department Saint Elizabeth's Healthcare System, Florence, KY. "This combination of a 120W high power laser and a fiber designed for enhanced energy delivery creates the most powerful solution for BPH. Vaporization rate, hemostasis and operative time are significantly improved. The learning curve is minimal as the technique is similar to TURP and the two foot pedal system gives the urologist an immediate sense of familiarity."

"As the gold standard treatment for BPH, Holmium Laser Enucleation of the Prostate (HoLEP) procedures have increasingly grown within the urology community in the U.S.," said Tzipi Ozer-Armon, CEO of Lumenis. "To meet the needs of a dynamic and growing market for urologic procedures in the United States the Pulse 120H platform is designed to be a superior solution also for Vaporization of the prostate, Flexible Ureteroscopy and Percutaneous Nephrolithotomy. We look forward to carrying on our collaboration with the urology community on the development of best-in-class solutions."

Lumenis will be exhibiting at booth #1317 throughout AUA. In addition to the educational symposium, the company plans to host a skills workshop series for hands-on training and instruction.

To view a schedule of the company's hosted events and to register for the symposium, please click here.

Saturday, May 16, 2015, Convention Center, Exhibit Hall

  • 10:00 AM – 12:00 PM  Enucleation Session (BPH Skills Workshop Series)
  • 12:00 PM – 1:30 PM   Vaporization Session (BPH Skills Workshop Series)
  • 1:30 PM – 3:30 PM   Enucleation Session (BPH Skills Workshop Series)
  • 3:30 PM – 5:00 PM   Vaporization Session (BPH Skills Workshop Series)

Sunday, May 17, 2015, Hilton Hotel, Grand Salon

  • 6:00 AM – 7:30 AM   Lumenis Breakfast Symposium: Pulse 120H
    Dr. Marc Beaghler and Dr. Khurshid Ghani

Lumenis invites AUA conference attendees to visit the Lumenis booth to explore and learn more about the company's portfolio of holmium lasers and accessories.

Source: http://www.lumenis.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.